Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.04M Sell
16,692
-87
-0.5% -$29.8K 1.74% 20
2026
Q1
$5.9M Buy
16,779
+391
+2% +$139K 1.84% 20
2025
Q4
$5.36M Sell
16,388
-354
-2% -$112K 1.66% 21
2025
Q3
$4.72M Sell
16,742
-634
-4% -$184K 1.46% 26
2025
Q2
$4.85M Sell
17,376
-380
-2% -$108K 1.5% 22
2025
Q1
$5.53M Buy
17,756
+311
+2% +$91.8K 1.77% 17
2024
Q4
$4.55M Sell
17,445
-623
-3% -$185K 1.4% 24
2024
Q3
$5.82M Sell
18,068
-217
-1% -$71K 1.75% 19
2024
Q2
$5.71M Buy
18,285
+288
+2% +$84.6K 1.84% 18
2024
Q1
$5.12M Buy
17,997
+199
+1% +$58.2K 1.66% 22
2023
Q4
$5.13M Buy
17,798
+222
+1% +$60.5K 1.76% 17
2023
Q3
$4.72M Buy
17,576
+490
+3% +$122K 1.83% 14
2023
Q2
$3.79M Buy
17,086
+297
+2% +$68.9K 1.41% 26
2023
Q1
$4.06M Buy
16,789
+260
+2% +$63.8K 1.6% 21
2022
Q4
$4.34M Buy
+16,529
New +$4.43M 1.79% 15

Other funds holding AMGN

Brady Family Wealth's AMGN Position: Q2 2026 in Review

Brady Family Wealth reduced its Amgen (AMGN) stake by 0.52% in Q2 2026, selling an estimated $29.8K and leaving 16,692 shares worth $6.04M. The position accounts for 1.74% of the portfolio, ranked #20.

Brady Family Wealth first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Brady Family Wealth held 16,692 shares of Amgen worth $6.04M as of Q2 2026.
  • Brady Family Wealth sold 87 Amgen shares in Q2 2026, an estimated $29.8K.
  • Amgen made up 1.74% of Brady Family Wealth's portfolio in Q2 2026, its #20 holding.
  • Brady Family Wealth first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Brady Family Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.